RePORT International Resources

This presentation by Prof. Friedrich Thienemann, University of Cape Town, shows preliminary findings of the StatinTB/ExtendTB trial.

An insightful presentation in which Dr. Redrigo Menezes of the University Center of Espirito Santo in Colatina, Brazil, explores the intersection of TB and planetary health. He examines how environmental factors, climate change, and ecosystem disruptions influence TB transmission and outcomes, highlighting the urgent need for integrated, systems-based approaches to address both human and environmental health challenges.

This symposium was presented at The Union World Conference on Lung Health in November 2025 about the work of RePORT International. Chairs: Marissa Alejandria and Sonali Sarkar Rajita Bhavaraju - RePORT International: Collaborative Science to Eliminate Tuberculosis John Carlo Malabad - TB Recurrence and Progression to Active TB: Burden, Determinants, and Implications on TB Prevention and Care Thomas Scriba - Immunological signatures of asymptomatic TB Felipe Ridolfi - Treatment of HIV-related TB: New Insights from RePORT Brazil Sonali Sarkar - Beyond the person with TB: Educational disruption in the wake of TB

This symposium was held at the Union World Conference on Lung Health in November 2025. Chairs: Marissa Alejandria and Sonali Sarkar Rajita Bhavaraju - RePORT International: Collaborative Science to Eliminate Tuberculosis John Carlo Malabad - TB Recurrence and Progression to Active TB: Burden, Determinants, and Implications on TB Prevention and Care Thomas Scriba - Immunological signatures of asymptomatic TB Felipe Ridolfi - Treatment of HIV-related TB: New Insights from RePORT Brazil Sonali Sarkar - Beyond the person with TB: Educational disruption in the wake of TB

Presented by Chetan Gadgil

Presented by Umesh Shaligram

Presented by Karen Dobos

The Resist TB Webinar, including David Holtzman of the Gates Medical Research Institute, discussing the PANTB collaboration Phase 2B2C trial updates.

Organization which offers periodic webinars, and has a monthly newsletter with current publications on DR-TB.

A PDF of the RESIST-TB June 2025 MDR-TB article list with abstracts. This includes 70 articles and 2 recent TB news articles with links and descriptions.

Results UK, together with Results International Australia, Results Canada and RESULTS U.S., has launched a new advocacy report - Fuelling the fight against the spread of tuberculosis: Nutrition is the missing ingredien. Despite being preventable and curable, tuberculosis (TB) remains one of the world‚ deadliest infectious diseases, affecting more than 10 million people and claiming over one million lives every year. Undernutrition is the leading risk factor for TB, contributing to nearly one million new cases annually, while more than two billion people continue to face moderate or severe food insecurity. The report makes the case for integrating nutrition and social protection into TB prevention and treatment programmes. Growing evidence shows these approaches are highly effective, cost-efficient, and can improve treatment outcomes while helping to break the cycle of disease, malnutrition and poverty. Modelling suggests that eliminating poverty and expanding social protection could reduce global TB incidence by as much as 84%.

Reviewing and Refining Your NIH Proposal Live NIH Online Workshop - Jan 24, 2025 Feb 20, 2025 Mar 21, 2025

Through the RACP Foundation, there is financial support to Fellows and trainees pursuing careers in medical research. Over 50 different fellowships, scholarships and grants are available annually, totalling over $2.5 million in funding. All applications across the different award categories will be assessed by review panels comprised of members of the Grants Advisory Committee, representatives from partner organisations, RACP Divisions, Faculties and Chapters, and other invited peer reviewers.

Rutgers Global Tuberculosis Institute offers education, training, research support, and program development resources for healthcare professionals and public health providers. Please explore the website for more details.

This guide summarizes drug-drug interactions (DDI) between drugs commonly used in primary care and rifamycins, in the context of treatment of latent tuberculosis infection (LTBI). Note that in the 2020 Guidelines for the Treatment of LTBI from the Centers for Disease Control and Prevention, rifampin and rifapentine are each included in preferred regimens for LTBI. Rifabutin is not included in a preferred regimen for LTBI and is included here only for reference. Many rifamycin DDIs can be managed with clinical monitoring or dosage modifications. In this table-based DDI guide, drugs are grouped by class; medical providers can access clinical recommendations for each drug and compare drug options within the same class.

Rutgers Global Tuberculosis Institute training archives feature past webinars covering diagnostics, treatment, prevention, and comorbidities, aimed at expanding individuals' knowledge and skills in tuberculosis care.

Rutgers Global Tuberculosis Institute webinar archives feature past webinars covering diagnostics, treatment, prevention, and comorbidities, aimed at expanding individuals' knowledge and skills in tuberculosis care.

This Notice of Funding Opportunity (NOFO) will support students at institutions without NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g. DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD, PharmD/PhD), and who intend careers as physician/clinician-scientists. Candidates must propose an integrated research and clinical training plan and a research training project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individual's potential to develop into a productive, independent physician/clinician-scientist. Please refer to the website for detail announcement and key dates.

Boost offers comprehensive training opportunities for immunization professionals that are both adaptive and technical. Our adaptive trainings pair with a specific immunization topic (e.g., life course immunization) and focus on building, developing and deepening leadership skills for community organizing. Graduates of our advanced training develop the capacity to deliver their own training to the Boost Community or within their own communities. The Stop TB Partnership is a supporting partner.

Sage's YouTube channel features videos on cutting-edge research, robust research methodologies, and high-quality educational resources to support students, educators, and researchers around the world.